Mission Statement
|
| "We support high tech spin-offs in Northwestern Switzerland." |
Start-up Center of the University of Basel and the FHNW
The BASEL INKUBATOR opened its doors in January 2010. In the first year, 12 start-up projects joined in.
BASEL INKUBATOR is a venture of the University of Basel, the University of Applied Sciences of Northwestern Switzerland FHNW, the Canton of Basel-Stadt, and "EVA - the Basel life sciences start-up agency”. It was established to support high-tech spin-offs of the Universities in the region. Other applicants are welcome as long as there is space available. The location at the Stücki Business Park ensures an optimal access with public transport as well as by car.
Start-up projects are supported already in a very early phase. Typically, the first contact is already established before the decision to create a start-up is made. The BASEL INKUBATOR provides an affordable infrastructure (offices and laboratories) and coaching in various fields. A start-up company can stay up to three years within the BASEL INKUBATOR. The aim is that a company can successfully build up in this environment until either first sales are established or a major investment round is successfully closed which provides the financial resources to further develop.
Currently the BASEL INKUBATOR houses 7 life sciences companies, 4 ICT projects and one start-up which combines nanotechnology with environmental applications. 8 are spin-offs of the university, 2 come out of FHNW, and two have another background. There is apparently a positive trend to convert research result into an own business. The common infrastructure fosters a productive interaction where the start-up companies profit from each other’s experiences.
Currently the companies in the BASEL INKUBATOR are Advanced Osteotomy Tools AOT AG (laser tools for surgery), Alma Biotherapeutics (antiinflammatory drugs), BioVersys AG (drug development, breaking antibiotic resistance), Cardiolynx AG (new drugs for CVS and diabetes), Cellec Biotek AG (bioreactors), Ennar Pharma AG (drugs to treat psoriasis), HighDim GmbH (high performance signal data processing), INOFEA GmbH (environmental analytics using nantechnology), Joe Security GmbH (IT security), Obexia AG (drug development for the treatment of cachexia and anorexia), Spheroidals GmbH (Nanomaterials for medical diagnosis and therapy), Vizago Research GmbH (imaging), and useKit AG (internet productivity).
The BASEL INKUBATOR is part of an interwoven network in the Basel area which is pushing the spirit of innovation in all domains. Additional needs of start-up companies like e.g. financing are covered within this network.
Please feel free to contact the BASEL INKUBATOR via info@basel-inkubator.ch.